• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,104
103
69
68
65

COUNTRY

63
19
16
10
9

CATEGORIES

  • 89
  • 128
  • 71
  • 72
  • 44
  • 43
  • 21
  • 16
  • 20
  • 22

PRICE

547
805
1,600
2,596

PUBLISHED

233
285
736
2,596

PRODUCT TYPE

2,449
72
61
12
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Anaplastic Astrocytoma - Pipeline Review, H1 2014

Anaplastic Astrocytoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H1 2014’, provides an overview of the Anaplastic Astrocytoma’s therapeutic...

February 2014
FROM

Rectal Cancer - Pipeline Review, H1 2014

Rectal Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H1 2014’, provides an overview of the Rectal Cancer’s therapeutic pipeline. This report...

February 2014
FROM

Medullary Thyroid Cancer - Pipeline Review, H1 2014

Medullary Thyroid Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H1 2014’, provides an overview of the Medullary Thyroid Cancer’s therapeutic...

February 2014
FROM

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014’, provides an overview of the Gastrointestinal...

February 2014
FROM

Mantle Cell Lymphoma - Pipeline Review, H1 2014

Mantle Cell Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This...

February 2014
FROM

Brain Cancer - Pipeline Review, H1 2014

Brain Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H1 2014’, provides an overview of the Brain Cancer’s therapeutic pipeline. This report provides...

February 2014
FROM

Follicular Lymphoma - Pipeline Review, H1 2014

Follicular Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline. This...

February 2014
FROM

Ewing Sarcoma - Pipeline Review, H1 2014

Ewing Sarcoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ewing Sarcoma - Pipeline Review, H1 2014’, provides an overview of the Ewing Sarcoma’s therapeutic pipeline. This report...

February 2014
FROM

Small-Cell Lung Cancer - Pipeline Review, H1 2014

Small-Cell Lung Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic...

February 2014
FROM

Refractory Multiple Myeloma - Pipeline Review, H1 2014

Refractory Multiple Myeloma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2014’, provides an overview of the Refractory Multiple Myeloma’s...

February 2014
FROM

Medulloblastoma - Pipeline Review, H1 2014

Medulloblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Medulloblastoma - Pipeline Review, H1 2014’, provides an overview of the Medulloblastoma’s therapeutic pipeline. This...

February 2014
FROM

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014’, provides an overview of the Opioid-Induced...

February 2014
FROM

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the Cutaneous...

February 2014
FROM

Peritoneal Cancer - Pipeline Review, H1 2014

Peritoneal Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2014’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline. This...

February 2014
FROM

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Metastatic Renal...

February 2014
FROM

Metastatic Colorectal Cancer - Pipeline Review, H1 2014

Metastatic Colorectal Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2014’, provides an overview of the Metastatic Colorectal...

February 2014
FROM

Colon Cancer - Pipeline Review, H1 2014

Colon Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides...

February 2014
FROM

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2014

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline...

February 2014
FROM

T-Cell Leukemia - Pipeline Review, H1 2014

T-Cell Leukemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘T-Cell Leukemia - Pipeline Review, H1 2014’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline. This...

February 2014
FROM

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2014

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2014’, provides an overview of the Squamous...

February 2014
FROM
Loading Indicator

Our Clients

Our clients' logos